Supplemental oxygen needs during sleep. Who benefits?

Respiratory Care

Volumn 58, Issue 1, 2013, Pages 32-44

  Owens, Robert L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Nocturnal oxygen desaturation; Overlap syndrome; Sleep deprivation

Indexed keywords

OXYGEN;

BREATHING EXERCISE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE ASSOCIATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPERCAPNIA; HYPOXEMIA; LUNG EMPHYSEMA; NEEDS ASSESSMENT; NONINVASIVE VENTILATION; OXYGEN DESATURATION; OXYGEN SUPPLY; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; REM SLEEP; RESPIRATION CONTROL; SLEEP DEPRIVATION; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SLEEP STAGE; WAKEFULNESS;

ANOXIA; HUMANS; HYPERCAPNIA; OXYGEN; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION; SLEEP; SLEEP APNEA, OBSTRUCTIVE; WAKEFULNESS;

EID: 84873639605     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01988     Document Type: Conference Paper

References (134)

1. Fencl V, Miller TB, Pappenheimer JR. Studies on the respiratory response to disturbances of acid-base balance, with deductions concerning the ionic composition of cerebral interstitial fluid. Am J Physiol 1966;210(3):459-472.
2. Issa FG, Remmers JE. Identification of a subsurface area in the ventral medulla sensitive to local changes in PCO2. J Appl Physiol 1992;72(2):439-446.
3. Severinghaus JW. Hans Loeschcke, Robert Mitchell and the medullary CO2 chemoreceptors: a brief historical review. Respir Physiol 1998;114(1):17-24.
4. López-Barneo J, López-López JR, Ureña J, González C. Chemotransduction in the carotid body: K+ current modulated by PO2 in type I chemoreceptor cells. Science 1988;241(4865):580-582.
5. Smith CA, Forster HV, Blain GM, Dempsey JA. An interdependent model of central/peripheral chemoreception: evidence and implications for ventilatory control. Respir Physiol Neurobiol 2010;173(3): 288-297.
6. Clement ID, Bascom DA, Conway J, Dorrington KL, O'Connor DF, Painter R, et al. An assessment of central-peripheral ventilatory chemoreflex interaction in humans. Respir Physiol 1992;88(1-2): 87-100.
7. Amann M, Blain GM, Proctor LT, Sebranek JJ, Pegelow DF, Dempsey JA. Group III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans. J Appl Physiol;109(4):966-976.
8. Poon CS, Tin C, Yu Y. Homeostasis of exercise hyperpnea and optimal sensorimotor integration: the internal model paradigm. Respir Physiol Neurobiol 2007;159(1):1-13; discussion 14-20.
9. Hatridge J, Haji A, Perez-Padilla JR, Remmers JE. Rapid shallow breathing caused by pulmonary vascular congestion in cats. J Appl Physiol 1989;67(6):2257-2264.
10. Lalani S, Remmers JE, MacKinnon Y, Ford GT, Hasan SU. Hypoxemia and low Crs in vagally denervated lambs result from reduced lung volume and not pulmonary edema. J Appl Physiol 2002; 93(2):601-610.
11. Paintal AS. Mechanism of stimulation of type J pulmonary receptors. J Physiol 1969;203(3):511-532.
12. Hamilton RD, Winning AJ, Horner RL, Guz A. The effect of lung inflation on breathing in man during wakefulness and sleep. Respir Physiol 1988;73(2):145-154.
13. Adrian ED. Afferent impulses in the vagus and their effect on respiration. J Physiol 1933;79(3):332-358.
14. Sant'Ambrogio G, Mortola JP. Behavior of slowly adapting stretch receptors in the extrathoracic trachea of the dog. Respir Physiol 1977;31(3):377-385.
15. Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW. Respiration during sleep in normal man. Thorax 1982;37(11):840-844.
16. Douglas NJ, White DP, Weil JV, Pickett CK, Martin RJ, Hudgel DW, et al. Hypoxic ventilatory response decreases during sleep in normal men. Am Rev Respir Dis 1982;125(3):286-289.
17. Douglas NJ, White DP, Weil JV, Pickett CK, Zwillich CW. Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis 1982;126(5):758-762.
18. Wiegand L, Zwillich CW, White DP. Sleep and the ventilatory response to resistive loading in normal men. J Appl Physiol 1988; 64(3):1186-1195.
19. Hudgel DW, Martin RJ, Johnson B, Hill P. Mechanics of the respiratory system and breathing pattern during sleep in normal humans. J Appl Physiol 1984;56(1):133-137.
20. Wheatley JR, White DP. The influence of sleep on pharyngeal reflexes. Sleep 1993;16(8 Suppl):S87-S89.
21. Niijima M, Kimura H, Edo H, Shinozaki T, Kang J, Masuyama S, et al. Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1999;159(6):1766-1772.
22. Trask CH, Cree EM. Oximeter studies on patients with chronic obstructive emphysema, awake and during sleep. New Engl J Med 1962;266:639-642.
23. Pierce AK, Jarrett CE, Werkle G Jr, Miller WF. Respiratory function during sleep in patients with chronic obstructive lung disease. J Clin Invest 1966;45(5):631-636.
24. Fletcher EC, Levin DC. Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short-and long-term oxygen. Chest 1984;85(1):6-14.
25. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Ehrhart M, Levi-Valensi P, et al. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J 1997;10(8):1730-1735.
26. Fletcher EC, Schaaf JW, Miller J, Fletcher JG. Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Review Respir Dis 1987;135(3):525-533.
27. Lewis CA, Fergusson W, Eaton T, Zeng I, Kolbe J. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax 2009;64(2):133-138.
28. Lacasse Y, Series F, Vujovic-Zotovic N, Goldstein R, Bourbeau J, Lecours R, et al. Evaluating nocturnal oxygen desaturation in COPD: revised. Respir Med 2011;105(9):1331-1337.
29. Mulloy E, Fitzpatrick M, Bourke S, O'Regan A, McNicholas WT. Oxygen desaturation during sleep and exercise in patients with severe chronic obstructive pulmonary disease. Respir Med 1995; 89(3):193-198.
30. Mulloy E, McNicholas WT. Ventilation and gas exchange during sleep and exercise in severe COPD. Chest 1996;109(2):387-394.
31. Krachman S, Minai OA, Scharf SM. Sleep abnormalities and treatment in emphysema. Proc Am Thorac Soc 2008;5(4):536-542.
32. Becker HF, Piper AJ, Flynn WE, McNamara SG, Grunstein RR, Peter JH, et al. Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med 1999;159(1):112-118.
33. O'Donoghue FJ, Catcheside PG, Eckert DJ, McEvoy RD. Changes in respiration in NREM sleep in hypercapnic chronic obstructive pulmonary disease. J Physiol 2004;559(Pt 2):663-673.
34. Ballard RD, Clover CW, Suh BY. Influence of sleep on respiratory function in emphysema. Am J Respir Crit Care Med 1995;151(4): 945-951.
35. Hudgel DW, Devadatta P. Decrease in functional residual capacity during sleep in normal humans. J Appl Physiol 1984;57(5):1319-1322.
36. Perin C, Fagondes SC, Casarotto FC, Pinotti AF, Menna Barreto SS, Dalcin PD. Sleep findings and predictors of sleep desaturation in adult cystic fibrosis patients. Sleep Breath 2012;16(4):1041-1048.
37. Cormick W, Olson LG, Hensley MJ, Saunders NA. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax 1986;41(11):846-854.
38. Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis 2009;51(5):363-370.
39. Fletcher EC, Donner CF, Midgren B, Zielinski J, Levi-Valensi P, Braghiroli A, et al. Survival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest 1992;101(3):649-655.
40. McNicholas WT, Fitzgerald MX. Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) 1984;289(6449):878.
41. Sin DD, Man SF. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 2005;83(1):8-13.
42. Fletcher EC, Luckett RA, Miller T, Costarangos C, Kutka N, Fletcher JG. Pulmonary vascular hemodynamics in chronic lung disease patients with and without oxyhemoglobin desaturation during sleep. Chest 1989;95(4):757-764.
43. Chaouat A, Weitzenblum E, Kessler R, Schott R, Charpentier C, Levi-Valensi P, et al. Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation. Eur Respir J 2001;17(5):848-855.
44. Shea SA, Winning AJ, McKenzie E, Guz A. Does the abnormal pattern of breathing in patients with interstitial lung disease persist in deep, non-rapid eye movement sleep? Am Rev Respir Dis 1989; 139(3):653-658.
45. Hargrave DR, Wade A, Evans JP, Hewes DK, Kirkham FJ. Nocturnal oxygen saturation and painful sickle cell crises in children. Blood 2003;101(3):846-848.
46. Kirkham FJ, Hewes DK, Prengler M, Wade A, Lane R, Evans JP. Nocturnal hypoxaemia and central-nervous-system events in sicklecell disease. Lancet 2001;357(9269):1656-1659.
47. Persson CG. On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter. Thorax 1985;40(12):881-886.
48. Salter HH. On asthma: its pathology and treatment. London: Churchill; 1860.
49. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988;85(1B):6-8.
50. Fitzpatrick MF, Engleman H, Whyte KF, Deary IJ, Shapiro CM, Douglas NJ. Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance. Thorax 1991;46(8):569-573.
51. Weersink EJ, van Zomeren EH, Koeter GH, Postma DS. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics. Am J Respir Crit Care Med 1997;156(4 Pt 1):1144-1150.
52. Kinsman RA, Yaroush RA, Fernandez E, Dirks JF, Schocket M, Fukuhara J. Symptoms and experiences in chronic bronchitis and emphysema. Chest 1983;83(5):755-761.
53. Klink ME, Dodge R, Quan SF. The relation of sleep complaints to respiratory symptoms in a general population. Chest 1994;105(1): 151-154.
54. Krachman SL, Chatila W, Martin UJ, Nugent T, Crocetti J, Gaughan J, et al. Effects of lung volume reduction surgery on sleep quality and nocturnal gas exchange in patients with severe emphysema. Chest 2005;128(5):3221-3228.
55. Mermigkis C, Stagaki E, Amfilochiou A, Polychronopoulos V, Korkonikitas P, Mermigkis D, et al. Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis. Med Princ Pract 2009;18(1):10-15.
56. White DP, Douglas NJ, Pickett CK, Zwillich CW, Weil JV. Sleep deprivation and the control of ventilation. Am Rev Respir Dis 1983;128(6):984-986.
57. Phillips BA, Cooper KR, Burke TV. The effect of sleep loss on breathing in chronic obstructive pulmonary disease. Chest 1987; 91(1):29-32.
58. Hetzel MR, Clark TJ, Branthwaite MA. Asthma: analysis of sudden deaths and ventilatory arrests in hospital. Br Med J 1977;1(6064): 808-811.
59. Cochrane GM, Clark JH. A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospitals in 1971. Thorax 1975;30(3):300-305.
60. Flenley DC. Sleep in chronic obstructive lung disease. Clin Chest Med 1985;6(4):651-661.
61. Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151(1):82-86.
62. Guilleminault C, Cummiskey J, Motta J. Chronic obstructive airflow disease and sleep studies. Am Rev Respir Dis 1980;122(3): 397-406.
63. Lopez-Acevedo MN, Torres-Palacios A, Elena Ocasio-Tascon M, Campos-Santiago Z, Rodriguez-Cintron W. Overlap syndrome: an indication for sleep studies? A pilot study. Sleep Breath 2009;13(4): 409-413.
64. Sanders MH, Newman AB, Haggerty CL, Redline S, Lebowitz M, Samet J, et al for the Sleep Heart Health Study. Sleep and sleepdisordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 2003;167(1):7-14.
65. Bednarek M, Plywaczewski R, Jonczak L, Zielinski J. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration 2005;72(2):142-149.
66. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Martinez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 2006;27(9):1106-1113.
67. Bradley TD, Rutherford R, Grossman RF, Lue F, Zamel N, Moldofsky H, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985;131(6):835-839.
68. Bradley TD, Rutherford R, Lue F, Moldofsky H, Grossman RF, Zamel N, et al. Role of diffuse airway obstruction in the hypercapnia of obstructive sleep apnea. Am Rev Respir Dis 1986;134(5): 920-924.
69. Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996;109(2):380-386.
70. Krieger J, Sforza E, Apprill M, Lampert E, Weitzenblum E, Ratomaharo J. Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients. Chest 1989;96(4):729-737.
71. Laks L, Lehrhaft B, Grunstein RR, Sullivan CE. Pulmonary hypertension in obstructive sleep apnoea. Eur Respir J 1995;8(4):537-541.
72. Weitzenblum E, Krieger J, Apprill M, Vallee E, Ehrhart M, Ratomaharo J, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988;138(2): 345-349.
73. Whyte KF, Douglas NJ. Peripheral edema in the sleep apnea/hypopnea syndrome. Sleep 1991;14(4):354-356.
74. Hawrylkiewicz I, Sliwiński P, Górecka D, Plywaczewski R, Zieliński J. Pulmonary haemodynamics in patients with OSAS or an overlap syndrome. Monaldi Arch Chest Dis 2004;61(3):148-152.
75. Chaouat A, Weitzenblum E, Krieger J, Sforza E, Hammad H, Oswald M, et al. Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP. Eur Respir J 1999;13(5):1091-1096.
76. Lavie P, Herer P, Lavie L. Mortality risk factors in sleep apnoea: a matched case-control study. J Sleep Res 2007;16(1):128-134.
77. Lavie P, Herer P, Peled R, Berger I, Yoffe N, Zomer J, et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995;18(3):149-157.
78. Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea. the overlap syndrome. Am J Respir Crit Care Med 2010;182(3):325-331.
79. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. New Engl J Med 2005; 352(12):1206-1214.
80. McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med 2009;180(8):692-700.
81. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57(10):847-852.
82. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60(11):925-931.
83. Mermigkis C, Kopanakis A, Foldvary-Schaefer N, Golish J, Polychronopoulos V, Schiza S, et al. Health-related quality of life in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease (overlap syndrome). Int J Clin Pract 2007;61(2): 207-211.
84. Teodorescu M, Consens FB, Bria WF, Coffey MJ, McMorris MS, Weatherwax KJ, et al. Predictors of habitual snoring and obstructive sleep apnea risk in patients with asthma. Chest 2009;135(5): 1125-1132.
85. Larsson LG, Lindberg A, Franklin KA, Lundback B. Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population. Respir Med 2001;95(5):423-429.
86. Julien JY, Martin JG, Ernst P, Olivenstein R, Hamid Q, Lemiere C, et al. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol 2009;124(2):371-376.
87. ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005;26(5):812-818.
88. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis 1988; 137(6):1502-1504.
89. Ciftci TU, Ciftci B, Guven SF, Kokturk O, Turktas H. Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med 2005;99(5):529-534.
90. Lafond C, Series F, Lemiere C. Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J 2007;29(2):307-311.
91. Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 2009;136(3):772-778.
92. Kaleyias J, Mostofi N, Grant M, Coleman C, Luck L, Dampier C, et al. Severity of obstructive sleep apnea in children with sickle cell disease. J Pediatr Hematol Oncol 2008;30(9):659-665.
93. Mermigkis C, Mermigkis D, Varouchakis G, Schiza S. CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: therapeutic difficulties and dilemmas. Sleep Breath 2010;16(1):1-3.
94. Sharma B, Feinsilver S, Owens RL, Malhotra A, McSharry D, Karbowitz S. Obstructive airway disease and obstructive sleep apnea: effect of pulmonary function. Lung 2011;189(1):37-41.
95. Kohler M, Craig S, Nicoll D, Leeson P, Davies RJ, Stradling JR. Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med 2008; 178(9):984-988.
96. Kessler R, Chaouat A, Weitzenblum E, Oswald M, Ehrhart M, Apprill M, et al. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J 1996;9(4):787-794.
97. Resta O, Foschino Barbaro MP, Brindicci C, Nocerino MC, Caratozzolo G, Carbonara M. Hypercapnia in overlap syndrome: possible determinant factors. Sleep Breath 2002;6(1):11-18.
98. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946.
99. Goldstein RS, Ramcharan V, Bowes G, McNicholas WT, Bradley D, Phillipson EA. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. New Engl J Med 1984;310(7):425-429.
100. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, et al. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 2008;4(2):157-171.
101. Ramsey R, Mehra R, Strohl KP. Variations in physician interpretation of overnight pulse oximetry monitoring. Chest 2007;132(3): 852-859.
102. Kuna ST. Portable-monitor testing: an alternative strategy for managing patients with obstructive sleep apnea. Respir Care 2010;55(9): 1196-1215.
103. Kuna ST, Badr MS, Kimoff RJ, Kushida C, Lee-Chiong T, Levy P, et al. An official ATS/AASM/ACCP/ERS workshop report: Research priorities in ambulatory management of adults with obstructive sleep apnea. Proc Am Thorac Soc 2011;8(1):1-16.
104. Chaney JC, Jones K, Grathwohl K, Olivier KN. Implementation of an oxygen therapy clinic to manage users of long-term oxygen therapy. Chest 2002;122(5):1661-1667.
105. Guyatt GH, Nonoyama M, Lacchetti C, Goeree R, McKim D, Heels-Ansdell D, et al. A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med medicine 2005;172(5):573-580.
106. Oba Y, Salzman GA, Willsie SK. Reevaluation of continuous oxygen therapy after initial prescription in patients with chronic obstructive pulmonary disease. Respir Care 2000;45(4):401-406.
107. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93(3):391-398.
108. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;1(8222): 681-686.
109. Wijkstra PJ, Guyatt GH, Ambrosino N, Celli BR, Guell R, Muir JF, et al. International approaches to the prescription of long-term oxygen therapy. Eur Respir J 2001;18(6):909-913.
110. Guell Rous R. Long-term oxygen therapy: are we prescribing appropriately? Int J COPD 2008;3(2):231-237.
111. Nisbet M, Eaton T, Lewis C, Fergusson W, Kolbe J. Overnight prescription of oxygen in long term oxygen therapy: time to reconsider the guidelines? Thorax 2006;61(9):779-782.
112. Samolski D, Tarrega J, Anton A, Mayos M, Marti S, Farrero E, et al. Sleep hypoventilation due to increased nocturnal oxygen flow in hypercapnic COPD patients. Respirology 2010;15(2):283-288.
113. Tarrega J, Anton A, Guell R, Mayos M, Samolski D, Marti S, et al. Predicting nocturnal hypoventilation in hypercapnic chronic obstructive pulmonary disease patients undergoing long-term oxygen therapy. Respiration 2011;82(1):4-9.
114. Fletcher EC, Luckett RA, Goodnight-White S, Miller CC, Qian W, Costarangos-Galarza C. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis 1992;145(5):1070-1076.
115. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 1999; 14(5):1002-1008.
116. Gorecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997;52(8):674-679.
117. Calverley PM, Brezinova V, Douglas NJ, Catterall JR, Flenley DC. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis 1982;126(2):206-210.
118. Anthonisen NR. Long-term oxygen therapy in moderate hypoxaemia. Thorax 1997;52(8):667-668.
119. Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med 2006;174(4):373-378.
120. Stoller JK, Panos RJ, Krachman S, Doherty DE, Make B. Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. Chest 2010;138(1):179-187.
121. Calverley PM. Oxygen-induced hypercapnia revisited. Lancet 2000; 356(9241):1538-1539.
122. Malhotra A, Schwartz DR, Ayas N, Stanchina M, White DP. Treatment of oxygen-induced hypercapnia. Lancet 2001;357(9259):884-885.
123. Alford NJ, Fletcher EC, Nickeson D. Acute oxygen in patients with sleep apnea and COPD. Chest 1986;89(1):30-38.
124. Beasley R, Aldington S, Weatherall M, Robinson G, McHaffie D. Oxygen therapy in myocardial infarction: an historical perspective. J R Soc Med 2007;100(3):130-133.
125. Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 1996;27(2): 353-357.
126. Mak S, Azevedo ER, Liu PP, Newton GE. Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure. Chest 2001;120(2):467-473.
127. Mak S, Egri Z, Tanna G, Colman R, Newton GE. Vitamin C prevents hyperoxia-mediated vasoconstriction and impairment of endothelium-dependent vasodilation. Am J Physiol 2002;282(6): H2414-H2421.
128. Martin RJ, Bartelson BL, Smith P, Hudgel DW, Lewis D, Pohl G, et al. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest 1999;115(5):1338-1345.
129. McNicholas WT, Calverley PM, Lee A, Edwards JC. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J 2004;23(6):825-831.
130. Ryan S, Doherty LS, Rock C, Nolan GM, McNicholas WT. Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease. Respiration 2010;79(6):475-481.
131. Sposato B, Mariotta S, Palmiero G, Ricci A, Gencarelli G, Franco C. Oral corticosteroids can improve nocturnal isolated hypoxemia in stable COPD patients with diurnal PaO2 > 60 mmHg. Eur Rev Med Pharmacol Sci 2007;11(6):365-372.
132. Kolodziej MA, Jensen L, Rowe B, Sin D. Systematic review of noninvasive positive pressure ventilation in severe stable COPD. Eur Respir J 2007;30(2):293-306.
133. McEvoyRD, Pierce RJ, Hillman D, Esterman A, Ellis EE, Catcheside PG, et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax 2009;64(7): 561-566.
134. Windisch W, Haenel M, Storre JH, Dreher M. High-intensity noninvasive positive pressure ventilation for stable hypercapnic COPD. Int J Med Sci 2009;6(2):72-76.